Associated Papers
Gene-gene and gene-environment interactions in lipodystrophy: Lessons learned from natural PPARγ mutants.
Broekema MF et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids, 2019
Peroxisome proliferator-activated receptor-gamma C190S mutation causes partial lipodystrophy.
Lüdtke A et al.
The Journal of Clinical Endocrinology and Metabolism, 2007
Impaired peroxisome proliferator-activated receptor gamma function through mutation of a conserved salt bridge (R425C) in familial partial lipodystrophy.
Jeninga EH et al.
Molecular Endocrinology (baltimore, Md.), 2007
A frameshift mutation in peroxisome-proliferator-activated receptor-gamma in familial partial lipodystrophy subtype 3 (FPLD3; MIM 604367).
Hegele RA et al.
Clinical Genetics, 2006
Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3).
Francis GA et al.
Bmc Medical Genetics, 2006
A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy.
Al-Shali K et al.
The Journal of Clinical Endocrinology and Metabolism, 2004
Select a paper to view details